TAT-N15 is a p55PIK inhibitor with remarkable anti-inflammatory activity and neuroprotective effects. TAT-N15 can significantly inhibit the activation of IL-6, IL-8, Akt, and NF-kappaB pathways, as well as suppress the protein expression of phosphorylated STAT3 and NF-kappaB. By inhibiting the activation of Akt, STAT3, and NF-kappaB pathways, TAT-N15 is used in research on acute conjunctivitis, allergic rhinitis, chronic obstructive pulmonary disease (COPD), and stroke[1][2].
Molekulargewicht:
3522.14
CAS Nummer:
[2415370-74-8]
Formel:
C155H250N48O40S3
Target-Kategorie:
Akt,Interleukin Related,NF-kappaB,STAT
Anwendungsbeschreibung:
Peptides
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
